You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MET amplification

Showing 1 - 25 of 1,958
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Non-squamous Non-small-cell Lung Cancer, Stage IV NSCLC, ROS1 Gene Rearrangement Trial in Toronto (Crizotinib)

Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Advanced Gastric Adenocarcinoma Trial in Seoul (Volitinib)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Amivantamab
  • +3 more
  • (no location specified)
Oct 30, 2023

NSCLC Trial in Shanghai (Savolitinib + Osimertinib, Pemetrexed + Cisplatin /Carboplatin)

Recruiting
  • Non-small Cell Lung Cancer
  • Savolitinib + Osimertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 29, 2021

NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

Recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • Toripalimab
  • +3 more
  • Guanzhou, Guangdong, China
    Guangdong Lung Cancer Institute, Guangdong Provincial People's H
Apr 4, 2023

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

NSCLC Trial in United States (capmatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • La Jolla, California
  • +7 more
Oct 5, 2022

NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Kashiwa, Chiba, Japan
  • +3 more
Jan 31, 2023

Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement Trial in Boston (Lorlatinib, Crizotinib,

Recruiting
  • Lung Cancer
  • +6 more
  • Boston, Massachusetts
  • +1 more
Mar 7, 2021

Solid Tumor, MET Exon 14 Skipping Mutation, MET Amplification Trial in Korea, Republic of (Tepotinib)

Recruiting
  • Solid Tumor
  • +2 more
  • Hwasun, Chonnam, Korea, Republic of
  • +21 more
Nov 30, 2020

Non Small Cell Lung Cancer (NSCLC), Metastases to the Brain Trial in Pittsburgh (cabozantinib)

Terminated
Has Results
  • Non Small Cell Lung Cancer (NSCLC)
  • Metastases to the Brain
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute- Hillman Cancer Center
Mar 8, 2021

Advanced (Stage IIIB/IV) NSCLC (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Trial in Worldwide

Active, not recruiting
  • Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification
  • Duarte, California
  • +140 more
Jun 7, 2022

Negative T790M Mutation and Met Amplification Trial in Beijing (Glumetinib)

Unknown status
  • Negative T790M Mutation and Met Amplification
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Apr 7, 2020

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

Colorectal Tumors Trial in Worldwide (Tepotinib, Cetuximab)

Active, not recruiting
  • Colorectal Neoplasms
  • Phoenix, Arizona
  • +66 more
Nov 19, 2021

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

NSCLC Trial in Worldwide (Tepotinib, Osimertinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Yuma, Arizona
  • +178 more
Dec 19, 2022

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

c-MET Expression and EGFR Gene Mutation Correlation With

Completed
  • Non-small Cell Lung Cancer Metastatic
  • Non-small Cell Lung Cancer Recurrent
    • Hwasun, Korea, Republic of
      Chonnam National University Hwasun Hospital
    Aug 1, 2021

    Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

    Active, not recruiting
    • Hematologic Cancers
    • +2 more
    • Villejuif, Ile De France, France
      Gustave Roussy
    Sep 5, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

    Not yet recruiting
    • Recurrent Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • (no location specified)
    Nov 30, 2022

    NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Orange, California
    • +40 more
    Aug 3, 2022